麻豆传媒

Fiona Kouyoumdjian is a Family Physician, Public Health and Preventive Medicine Physician and Epidemiologist. She received her BA with Honors from Brown University, her MD from Dalhousie University, her MPH from the Johns Hopkins Bloomberg School of Public Health, and her PhD in Epidemiology from the University of Toronto Dalla Lana School of Public Health. She completed residency training at the University of Toronto and a CIHR Fellowship at St. Michael鈥檚 Hospital.

Fiona leads a program of research focused on the health status and health care of people who experience imprisonment. Her research foci are decreasing imprisonment, improving health care and health promotion for people in prison, and supporting successful re-integration to the community for people on release from prison.

Fiona is an Assistant Professor in the Department of Family Medicine at McMaster University and an Adjunct Scientist at ICES.

Dr. Kannan Ramar is a Professor of Medicine at the division of Pulmonary and Critical Care Medicine, Center for Sleep Medicine, Mayo Clinic, Rochester, MN, USA. He is the Safety Officer for Mayo Clinic, Rochester. He also serves as the Assistant Dean for Clinical Learning Environment Optimization (CLEO) at the Mayo Clinic School of Graduate Medical Education (MCSGME) and is the president for the American Academy of Sleep Medicine (AASM). 

Dr. Ramar served as the Education Chair for the Pulmonary and Critical Care Medicine division and as the Program Director for the Pulmonary and Critical Care Medicine, Critical Care Internal Medicine, and Pulmonary Disease Fellowship programs at Rochester, MN. Dr. Ramar has served as quality chair for the Medical Intensive Care Unit between 2010 and 2013, and as the quality chair for the Division of Pulmonary and Critical Care Medicine between 2013 and 2014. He was the Mayo Quality Fellows Program chair between 2015 and 2019, and serves on the Graduate Medical Education Committee, Mayo Clinic Quality Academy Education Committee and serves for the Mayo Clinic Proceedings Editorial Board as the Pulmonary Medicine section editor. He currently serves as a board member on AASM, AASM Foundation, American Board of Sleep Medicine, and recently on the Minnesota Alliance for Patient Safety.

Dr. Joyce Zazulak is a Full Professor in the Department of Family Medicine at McMaster University and practices medicine at the Maternity Centre of Hamilton.

Dr. Zazulak鈥檚 academic areas of interest include teaching about communication skills and patient-centered care, Narrative Medicine, and Health Humanities. She is the Faculty Development Director for the Department of Family Medicine, as well as the Faculty Lead for Academic Support and Resident Remediation. Dr. Zazulak  has a particular interest in the use of art and visual literacy in the training of healthcare professionals and, in collaboration with the McMaster Museum of Art, has developed a visual literacy program for family medicine residents called 鈥淭he Art of Seeing.鈥�  Dr. Zazulak is also one of the co-creators of the Indigenous Teaching Through Art Program.

Dr. Oliver is an Associate Professor in the Department of Family Medicine at McMaster University.

He joined the Department in 2004 and took on a full-time faculty position in 2007.

Dr. Oliver鈥檚 passion for elder care lead him to take on the position as Care of the Elderly Curriculum Coordinator from 2006 鈥� 2015. This role allowed him to develop many innovative programs for the Department, including a Long Term Care clinical rotation for residents and a successful annual CME event entitled 鈥淐are of the Elderly: Perspectives for Primary Care鈥�. His clinical commitment to this patient population continues with weekly nursing home rounds and house-calls to frail elderly patients.

He is also co-PI on Health Tapestry, a multi-year, multi-site primary care based intervention aimed at promoting optimal aging in community dwelling older adults. Dr. Oliver鈥檚 interest in improving access for patients in primary care resulted in study and co-development of an Advanced Access booking model in the McMaster Family Health Team. This model allows patients better access to their primary care team by having the majority of booking spots available for same day appointments.

Dr. Oliver is the Principle Investigator on a research project designed to better understand how and why patients make the choices they do, when calling in to book an appointment with their family doctor. On the academic front, Dr. Oliver is assisting the Department with several educational leadership roles including Co-Education Coordinator at McMaster Family Practice (2011-16), Hamilton Site Director and CBRT Education Coordinator (2012-2013) and Behavioural Sciences Co-Coordinator (2013-).

Dr. Oliver has held several academic leadership roles in the last few years, including Education Coordinator at MFP (2011-16), MHBS Curriculum Coordinator (2013-2019) and is currently the Medical Director at McMaster Family Practice (2016-present)鈥�

Dr. Amy Montour is an Haudenosaunee woman from the Six Nations of the Grand River Territory. She has completed Bachelor of Science in Nursing, Master of Science in Nursing, and Doctor of Medicine degrees at McMaster University. Amy works clinically as a palliative care physician and as an advocate for Indigenous health. As full-time faculty with the McMaster University Department of Family Medicine she serves as the Site Director for the Grand Erie Six Nations site and as an Indigenous Health consultant.

Balaji Narasimhan directs the Nanovaccine Institute based at Iowa State University. The institute is looking for new and better ways to prevent disease, including influenza and cancers. Nanovaccines, unlike current vaccines, are based on tiny particles that can send pathogen-like signals to immune cells. They can prevent disease. They can boost the immune system鈥檚 own response to disease. Production is quick. Storage is easy. And the technology is sustainable. 鈥淭his is truly one of the dream teams working on vaccine research anywhere in the world,鈥� Narasimhan said.

I was born and raised in southwest Missouri. My parents raised a few cattle and operated a small meat locker. I received a B.S. in economics with minors in mathematics, history, and astronomy from Southwest Missouri State University in 1991. I then moved to Iowa in the summer of 1991 to pursue graduate education. I received a Ph.D. in economics and statistics in 1999 from Iowa State University.

Upon graduation, I joined the staff for the Center for Agricultural and Rural Development (CARD) at Iowa State. I served as the U.S. Policy and Insurance Analyst with the Food and Agricultural Policy Research Institute (FAPRI) and a Scientist with CARD. For FAPRI, I was responsible for directing econometric and modeling efforts for the crop insurance component of the FAPRI modeling system. For CARD, I served in multiple roles, concluding as the head of the Biorenewables Policy Division and examined the interactions between the agricultural and energy sectors.

My research has examined the interaction between the agricultural commitments within the World Trade Organization (WTO) and the agricultural policies and programs of WTO members, crop insurance, international trade, biofuel policy, federal agricultural policy, and crop marketing.

Dr Dumuid’s research seeks to identify the healthiest way to spend our time across daily activities such as sleeping, screen time and exercise. Because there are only 24 hours in any day, this involves a balancing act between activities. Dr Dumuid’s work develops novel analytical models that explore how to get the balance right, not only for one aspect of health (e.g., obesity), but for overall health and wellbeing.

Papatla can talk about the potential of using data science to analyze social media as another way to measure public opinion in an election campaign. Papatla is a professor of marketing at UW-Milwaukee and co-director of the Northwestern Mutual Data Science Institute. He helps to oversee the institute's Elecurator project, which uses a variety of data sources, including online and social media, traditional polling methods and political advertisements, to determine what issues are on the minds of voters. This big data look at voter behavior can help drive online strategies and outreach by candidates. Papatla also can speak about marketing and advertising trends, including why Instagram posts by consumers can affect how other consumers respond to brands, and how consumers engage with brands on social media platforms like Facebook.

鈥�	President, UH Harrington Heart & Vascular Institute
鈥�	Director, Interventional Cardiovascular Center, University Hospitals
鈥�	Co-Director, Vascular Center, Harrington Heart & Vascular Institute, University Hospitals
鈥�	Professor, CWRU School of Medicine

Dr. Mehdi H. Shishehbor, DO, MPH, PhD is an expert in vascular medicine and minimally invasive, catheter-based procedures such as angioplasty, stent grafts, stenting, atherectomy and intravascular ultrasound to treat coronary, carotid, abdominal aortic aneurysms, and peripheral arterial and venous diseases. He is also an expert on minimally invasive approaches to reconstruct lower extremity arteries in order to treat critical limb ischemia and prevent amputation. His work in this area has been recognized locally, nationally and internationally. 

Prior to joining University Hospitals, Dr. Shishehbor directed the Endovascular Program at the Cleveland Clinic from 2009 to May 2017 and trained over 40 interventional fellows and over 400 physicians nationally on advanced techniques for limb salvage.

Dr. Shishehbor is widely published on cardiovascular epidemiology, interventional cardiology outcomes, and techniques in leading journals such as the Journal of American Medical Association, New England Journal of Medicine, and Journal of the American College of Cardiology and Circulation. He also is the author of a number of editorials, textbook chapters, co-author of a book on coronary intensive care and cardiac catheterization and a manuscript reviewer for several prestigious medical publications, including the Journal of the American Medical Association, Journal of the American College of Cardiology, American Journal of Cardiology, and Archives of Internal Medicine.

Dr. Shishehbor鈥檚 research interests include clinical outcomes in interventional cardiology, carotid and endovascular interventions. He has a special interest in novel minimally invasive percutaneous approaches to treat cardiac, venous and arterial diseases and has worked with a number of startup companies and early stage devices. An area of intense work has been around perfusion assessment in CLI. He currently has four ongoing prospective studies to evaluate novel perfusion devices in CLI. Additionally he is currently serving as the national principal investigator for five randomized trials related to vascular disease.

Dr. Shishehbor earned his undergraduate degree in chemistry at Florida International University, Miami, followed by a Doctor of Osteopathy (DO) from Nova Southeastern University in Fort Lauderdale, Fla. He completed a Master鈥檚 degree in public health at Cleveland State University in 2004 and a doctorate in epidemiology at Case Western Reserve University in 2013. Dr. Shishehbor is board certified in internal medicine, cardiovascular medicine, interventional cardiology, vascular medicine, and endovascular/carotid intervention. 

Paul Schiff Berman, the Walter S. Cox Professor of Law at The George Washington University Law School, is one of the world鈥檚 foremost theorists on the effect of globalization on the interactions among legal systems. He recently edited The Oxford Handbook of Global Legal Pluralism (Oxford University Press 2020) is the author of over sixty scholarly works, including Global Legal Pluralism: A Jurisprudence of Law Beyond Borders, published by Cambridge University Press in 2012. He was also among the first legal scholars to focus on legal issues regarding online activity, and he is co-author of one of the leading casebooks in the field.

In addition to his scholarly work, Professor Berman has extensive experience in university and law school administration, having served as Vice Provost for Online Education and Academic Innovation at The George Washington University from 2013-16; Dean of The George Washington University Law School from 2011-13; and Dean of the Sandra Day O鈥機onnor College of Law at Arizona State University from 2008-11. Professor Berman has previously served as the Jesse Root Professor of Law at the University of Connecticut School of Law, where he taught from 1998-2008. For the 2006鈥�07 academic year, Professor Berman was a Visiting Professor and Visiting Research Scholar at Princeton University in the Program in Law and Public Affairs. Since 2016, he has been a visiting global scholar at Queen Mary University of London, in 2014 he was a Distinguished Visiting Lecturer at the Centre for Transnational Studies at the University of Bremen, Germany, and in 2018, he was Distinguished Visiting Professor at Southern Cross University in Australia. He also has served two terms on the Organizing Committee of the Association for the Study of Law, Culture, and the Humanities and was Chair of the International Law and Technology Interest Group of the American Society of International Law.

Professor Berman graduated summa cum laude from Princeton University in 1988 and earned his law degree from New York University in 1995. During law school, he served as Managing Editor of the NYU Law Review and received the University Graduation Prize for the graduating law student with the highest cumulative grade point average. He later clerked for Chief Judge Harry T. Edwards of the United States Court of Appeals for the District of Columbia Circuit and for Justice Ruth Bader Ginsburg of the Supreme Court of the United States.

Prior to entering law school, Professor Berman was a Professional Theater Director in New York City and Artistic Director of Spin Theater, a not-for-profit theater company. He was also administrative director of two other not-for-profit theater companies in New York City: The Wooster Group and Richard Foreman鈥檚 Ontological-Hysteric Theatre at St. Mark鈥檚 Church.

Bolton has authored peer-reviewed book chapters and journal articles on presidential debates, campaign advertising and nominating conventions. His work has appeared in books including An Unprecedented Election: Media, Communication, and the Electorate in the 2016 Campaign and The Praeger Handbook of Political Campaigning in the United States, as well as scholarly publications such as the American Communication Journal.

Casey Burgat is the director of the Legislative Affairs program at the Graduate School of Political Management. Prior to joining GSPM, Dr. Burgat was a Senior Governance Fellow at the R Street Institute where his research focused on issues of congressional capacity and reform. In this role, Casey wrote regularly for both scholarly and journalistic publications, including CNN, the Washington Post, Politico, and appeared on a variety of television and radio outlets. Dr. Burgat is currently finishing on a co-authored book on congressional policy procedures and strategies, to be published by the University of Michigan Press.

 

Previously, Casey worked at the Congressional Research Service, where he served in the Executive Branch Operations and the Congress & Judiciary sections. There, he was responsible for responding to congressional requests about federal rulemaking, issues of congressional reform, the president鈥檚 role in federal budgeting, federal advisory committees, and congressional staffing.

Casey is a graduate of Arizona State University, with a bachelor鈥檚 degree in political science. He also holds a master鈥檚 in political management from George Washington University and received his doctorate in government and politics from the University of Maryland, College Park, where his dissertation focused on the impacts of congressional staff.

Assistant Professor in the Political Science department at Wellesley College and an affiliate of the Taubman Center for American Politics and Policy at Brown University. My research focuses on race and ethnicity politics, public opinion, campaigns and elections, and experimental and survey methodology. My articles have been published or are forthcoming in Political Research Quarterly, Politics Groups and Identities, and Journal of Education and Social Policy. 

鈥婱y book project, Changing Temptations: The Evolution of Racialized Messaging in the Obama and Trump Eras, explains the causes and consequences of racial appeals in U.S. politics. I propose a theory of differential norms, in which different histories of racial politics have generated different norms of acceptable rhetoric targeting blacks, Latinos, and Muslims. Using original survey experiments, I show that the effectiveness of explicit racial appeals varies systematically by the group being targeted: explicit appeals to racial prejudice increase support for Republican candidates who target Latinos and Muslims but not blacks, whereas explicit appeals to racial equality increase support for Democratic candidates. These results suggest greater attention to target groups is essential for understanding how racial appeals work and help to explain the contours of racial priming in contemporary American political discourse. 

Dr. Gaber serves as Chair of Houston Methodist's Department of Surgery.  He received his first academic appointment in 1987, as an Assistant Professor in the Department of Surgery at the University of Tennessee in Memphis. He became an Associate Professor there in 1991, and received his full professorship and was named to the Baptist Memorial Health Care Foundation chair of excellence in transplantation in 1994. While at the University of Tennessee, Dr. Gaber also held professorships in the Departments of Pharmacy and in the College of Nursing. He was also the Medical Director for the University of Tennessee Bowld Hospital, and the Methodist University Transplant Institute.

Dr. Gaber is a prolific researcher and has authored over 300 scientific papers, as well as more than 340 abstracts and numerous book chapters, and his research has been funded by numerous grants from the National Institutes of Health, the Juvenile Diabetes Research Foundation, and several national and local foundations. Dr. Gaber assumed his positions at the Houston Methodist Hospital and Research Institute in Houston in 2006.

While also conducting transplant immunotherapy research for liver and kidney whole organ transplants and allografts, the main focus of Dr. Gaber麓s research is in the transplantation of islets to alleviate diabetic complications. He and his collaborators have developed the protocol for long term islet culture and described the clinical transplantation of islets through the intestinal veins. Dr. Gaber麓s current studies center on the testing of gene therapy and other approaches to test for islet viability and assist the transplanted islets to develop a sustaining blood supply and resist rejection by the recipient's immune system.

Dr. Hassan N. Ibrahim is currently the chief of nephrology and the director of the living donor kidney transplant program at Houston Methodist. He is a professor of medicine at the Houston Methodist Academic Institute. Prior to joining Houston Methodist in May 2017, he was a tenured professor at the University of Minnesota, the director of the Division of Renal Diseases and Hypertension, and the medical director of the kidney transplant program.

After finishing his basic medical training in Detroit, he began his career as a clinical fellow in nephrology at the University of Minnesota in 1995, then spent three years in the laboratory studying basic mechanisms of progression of kidney disease. He subsequently obtained a master鈥檚 degree in clinical research from the School of Public Health at the University of Minnesota.

At the University of Minnesota, Dr. Ibrahim was heavily involved in education and served as the director of both the general nephrology and transplant nephrology fellowships. He was also the principal investigator on an NIH-funded training grant in renal investigations for 10 years. He has also been involved in teaching medical students, medical residents, graduate students, and junior faculty. Many of his trainees have advanced to leadership positions both in the US and abroad.

His research interests include chronic kidney disease, kidney transplantation, and outcomes of kidney donors. Over the years he has received funding for his research from the National Institute of Health, the Juvenile Diabetes Research Foundation, and other agencies. He has spent the last 15 years studying the outcomes of kidney donation. With his colleagues, they have been able to provide critical information that assists both kidney donors and health professionals in assessing the long-term risks of kidney donation. He is a reviewer for numerous general medical and specialty journals and has served on many study sections for the National Institutes of Health, the CDC, and also the National Kidney Foundation.

Dr. Ibrahim is a frequently invited speaker at both national and international venues.
Since his arrival at Houston Methodist, Dr. Ibrahim has dedicated most of his time to building the academic nephrology division, expanding the live donor program, and mentoring general nephrology and transplant fellows.

Dr. John Volpi specializes in the evaluation of hospitalized patients and outpatients with cerebrovascular disease, such as ischemic and hemorrhagic stroke as well as the critical care of patients with other neurological diseases. His primary clinical and research interests are in the management and prevention of ischemic stroke and the critical care of patients with neurological illnesses, such as intracerebral hemorrhage, trauma, and nervous system infections.

Dr. Volpi麓s research interests are in the management and prevention of ischemic stroke, and the critical care of patients with neurological illnesses such as intracerebral hemorrhage, epilepsy, and nervous system infections. His studies also involve the use of ultrasound in the evaluation of blood flow to the brain and development of novel therapies for improving patient outcomes in stroke.

Stanley H. Appel, M.D. is the Peggy and Gary Edwards Distinguished Endowed Chair for the Treatment and Research of ALS, Department of Neurology, Neurological Institute, Houston Methodist Hospital, and Professor of Neurology at Weill Medical College of Cornell University. He was previously Chair of the Department of Neurology at Baylor College of Medicine as well as Chief of the Neurology division and the James B. Duke Professor of Medicine at Duke University Medical Center, North Carolina. Dr. Appel is a native of Massachusetts and received his Bachelor Degree at Harvard University and his Medical Degree from Columbia College of Physicians and Surgeons. He is Director of the MDA/ALS Research and Clinical Center at the Methodist Neurological Institute, and past Director of a National Institute of Aging Alzheimer鈥檚 Disease Research Center.

Dr. Appel is a member of numerous professional societies and committees and is the author of 15 published books and over 350 articles on topics such as ALS, neuromuscular disease, Alzheimer鈥檚 Disease, and Parkinson鈥檚 Disease. He has received a number of awards for his accomplishments in Neurology and Biochemistry, including the Gold Medal Award in 1997 from Columbia College of Physicians and Surgeons for 鈥淒istinguished Achievements in Medicine鈥�, the Sheila Essey Award in 2003 from the American Academy of Neurology for 鈥渙utstanding research in Amyotrophic Lateral Sclerosis鈥�, Elected Fellow of the American Association for the Advancement of Science in recognition of the 鈥渄edication and commitment to advancing science and serving society鈥� in 2003, Baylor College of Medicine Alumni Association Distinguished Faculty Award in 2004, MDA鈥檚 Wings Over Wall Street Diamond Award in 2004, Texas Neurological Society Lifetime Achievement Award in 2005 and the Forbes Norris Award for 鈥渃ompassion and love for humanity in research and treatment in patients with ALS鈥� from the International Alliance of ALS/MND Associations in 2005, and the Museum District Business Alliance Award in recognition of his commitment to research, patient care, and education, 2007, and the recipient of the Houston Academy of Medicine 2008 John P. McGovern Compleat Physician Award. He is also named 2008 Best of the Best Physicians by the Medical Journal of Houston.

Research in Dr. Appel鈥檚 laboratory has focused on developing new insights into neurodegenerative diseases with primary emphasis on ALS. His studies of mutant SOD transgenic mice have documented that neuroinflammation and activated microglia are neuroprotective during the early stages of the disease and cytotoxic during the late stages of the disease. The early stages start within motor neurons and appear cell-autonomous, whereas later stages involve innate immune glia and are non-cell-autonomous. These two stages appear to be modulated by peripheral T-cells that enter the CNS at sites of neuronal injury; Th2 and regulatory T-cells are increased in early stages and appear to provide neuroprotection, while Th1 T-cells are increased in later stages and mediate cytotoxicity. Transplantation of ALS mice with regulatory T cells prolonged disease duration by more than 80%. Our comparable studies in human ALS have employed PCR techniques to confirm the presence of activated microglia and to demonstrate the presence of CD4 T-cells as well as immature and mature dendritic cells and enhanced chemokine signaling. Our laboratory was the first to document that regulatory T lymphocytes modulate disease progression in ALS patients. More specifically, regulatory T lymphocytes are decreased in ALS patients that progress at a faster rate; the levels of Treg may thus serve as a biomarker of rates of disease progression. His current efforts are focused on enhancing the protective immunity of Treg cells and anti-inflammatory microglia, and decreasing the pro-inflammatory immunity of Th1 effector lymphocytes and proinflammatory microglia.

An actively practicing physician leader/executive with extensive (20+ years) hands-on experience in hospital operations, and physician practice management. 

Dr. Sarah N Pletcher is the Vice President and Executive Medical Director of Virtual Care at Houston Methodist. In this role, she leads the health system on strategies, processes, practice and education around system-wide virtual care and digital health programs across the organization.

Prior to joining Houston Methodist, Dr. Pletcher was the founder of the Centers for Connected Care & Telehealth at Dartmouth-Hitchcock, where she led the health system in the selection and implementation of new strategies utilizing telehealth technology platforms, and developed new clinical products and telemedicine programs across multiple specialties, and in multiple settings. As a consultant, Dr. Pletcher has advised health systems, policymakers, and investors about disruptive technologies and new business models that can provide value in serving populations. She is frequently sought as a thought leader and invited speaker in areas of telemedicine, health, innovation, clinical quality improvement, provider education, and rural program development; and has been the principal investigator on over 15 million dollars of grant and foundational funding to advance these initiatives.